Trial Profile
An open-label, 2-period, sequential treatment, drug interaction study to evaluate the effect of low-dose ritonavir on bupropion pharmacokinetics in healthy volunteers
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Ritonavir
- Indications HIV infections; Major depressive disorder; Seasonal affective disorder; Smoking withdrawal
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 12 Jul 2007 New trial record.